Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    YFK

No quotes available
-- EUR   0.00%
05/20 3SBIO INC. : (01530) withdraws breast cancer drug application
03/04 3SBIO : Bought CNY3.9bn Shares in CPGJ
03/04 3SBIO : adds stake in CP Guojian Pharma at Rmb3.9bn
SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in research, development, manufacturing and marketing of biopharmaceutical products

3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products.

It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.

The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.
Managers
NameAgeSinceTitle
Jing Lou MD, PhD531993Chairman, President & Chief Executive Officer
Wei hong Xiao-2016Chief Operating Officer
Bo Tan, MBA412009Chief Financial Officer, Executive Director & EVP
Yong Fu Chen582011Director-Financial Department
Dong Mei Su, PhD462012Director & Chief Technology Officer
Bin Huang, MBA551993Executive Director & VP-Human Resources
Dong Liu, MBA432014Non-Executive Director
Dong LV, PhD412014Non-Executive Director
Tian Ruo Pu, MBA482014Independent Non-Executive Director
David R. Parkinson MD, PhD652014Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 2,515,313,570 936,973,010 37.3% 0 0.0% 37.3%
Shareholders
NameEquities%
CITIC Private Equity Funds Management Co., Ltd. 712,258,360 28.3%
Jing Lou, MD, PhD 599,367,030 23.8%
Bo Tai 115,549,920 4.59%
Dan Lou 62,001,010 2.46%
HSBC Global Asset Management (Hong Kong) Ltd. 39,032,000 1.55%
Bin Huang, MBA 33,919,350 1.35%
Allianz Global Investors Asia Pacific Ltd. 29,341,000 1.17%
Dong Mei Su, PhD 26,403,630 1.05%
The Vanguard Group, Inc. 16,486,500 0.66%
BlackRock Investment Management (UK) Ltd. 14,118,491 0.56%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
CSL LIMITED
ALEXION PHARMACEU..
BAXALTA INC
GRIFOLS SA
CHONGQING ZHIFEI ..
3SBIO INC
JIANGXI BOYA BIO-..
BEIJING TIANTAN B..
ABCAM PLC
PROMETIC LIFE SCI..
STAIDSON (BEIJING..
-
HUGEL INC
ZHEJIANG WOLWO BI..
BIOTEST AG
PHARMA MAR SA
ESSEX BIO-TECHNOL..
-
VITAE PHARMACEUTI..
REPROCELL INCORPO..
-
CHEMOCENTRYX INC
PHYTOHEALTH CORP
-
Sector Pharmaceuticals
3SBio Inc. (ADR) : Connections
Shanghai Aoxi Technology Information Consulting Co., Ltd.
Shenzhen Baishitong Technology Development Co., Ltd.
Excel Partner Holdings Ltd.
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd.
Taizhou Huan Sheng Investment Management Co., Ltd.
Ample Harvest Investments Ltd.
Zhejiang Sunshine Pharmaceutical Co., Ltd.
Beingmate Group Co. Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Hong Kong Sansheng Ltd.
Collected Mind Ltd.
Mudanjiang Youbo Pharmaceutical Co., Ltd.
The Multiple Myeloma Research Foundation, Inc.
UTStarcom, Inc.
Zyngenia, Inc.
Liaoning Sunshine Science & Technology Development Co. Ltd.
Shenyang Sunshine Pharmaceutical Co. Ltd.
Tocagen, Inc.
Hongkong Sansheng Medical Ltd.
Liaoning Sunshine Bio-Pharmaceutical Co. Ltd.
CFA Institute
Multiple Myeloma Research Consortium
Company contact information
3SBio, Inc.
Shenyang Economy & Technology Dev
No. 3 A1, Road 10
Shenyang, Liaoning 110027

Phone : +86.24.2538.6000
Fax : +86.24.2581.1821
Web : www.3sbio.com
© 2016 People , Fundamentals and Ownership